Galiximab Biosimilar, Anti-human CD80 Monoclonal Antibody
$250.00 – $2,000.00
Galiximab Biosimilar, CD80 Monoclonal Antibody. The research grade Galiximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C048P |
|---|---|
| Product Name | Galiximab Biosimilar, Anti-human CD80 Monoclonal Antibody |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | Cluster of differentiation 80, CD80, B7-1, B7, B7.1, BB1, CD28LG, CD28LG1, LAB7 |
| Summary | Recombinant Humanized IgG1 Monoclonal Antibody. |
| Source/Host | The anti-human CD80 monoclonal antibody galiximab biosimilar was produced in mammalian cells. |
| Specificity/Sensitivity | The in vivo grade galiximab biosimilar specifically binds to the human CD80. |
| Applications | ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by galiximab. |
| Form Of Antibody | 0.2 uM filtered solution, pH 6.0, no stabilizers or preservatives. |
| Endotoxin | <1 EU/mg of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The research grade galiximab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade Galiximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C048P: Galiximab Biosimilar, Anti-human CD80 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Background
A humanized IgG1 monoclonal antibody directed against CD80, the natural ligand for the T-cell antigen CD28 which mediates T-cell and B-cell adhesion. Galiximab binds to CD80 expressed on the cell surfaces of follicular lymphomas, resulting in antibody-dependent cell-mediated cytotoxicity (ADCC). CD80 is expressed on activated B-cells and gamma-interferon-stimulated monocytes and is often expressed at low levels on the surfaces of follicular lymphoma cells and other lymphoid malignancies.
Galiximab, an IgG(1) anti-CD80 antibody, binds to CD80, a costimulatory molecule involved in T-cell activation. Reduction in lesional, activated T cells induces improvement in psoriatic plaques.
Please remember our product information: Galiximab Biosimilar, CD80 Monoclonal Antibody: C048P Syd Labs
Additional information
| Size | 1 mg, 20 mg, 5 mg |
|---|